SCHEMBL918872

SCHEMBL918872

CC(C)(C)C1C=CC(=O)CC1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3988933 1.00 NFKB1 (0.33) NFKB1NFKB2RELA
SCHEMBL1648671 0.83 NFKB1 (0.34) NFKB1NFKB2RELA
SCHEMBL31473481 0.80 SLC2A1 (0.37) NFKB1NFKB2RELA
SCHEMBL3192675 0.77 NFKB1 (0.42) NFKB1NFKB2RELA
Water SCHEMBL5170044 0.76 NFKB1 (0.41) NFKB1NFKB2RELA
SCHEMBL17918196 0.75 NFKB1 (0.39) NFKB1NFKB2RELA
SCHEMBL4790845 0.75
SCHEMBL4911808 0.75
SCHEMBL31473482 0.74
SCHEMBL3983475 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138485-A1 Chemical synthons and intermediates PURDUE RESEARCH FOUNDATION 2004-07-15 US claimed
CN-119678921-A Cyclohexene derivative with attraction effect on carpiotosia borer as well as preparation method and application thereof 华东理工大学 2025-03-25 CN disclosed
EP-2851359-B1 METHOD FOR PRODUCING 4,4''-DIHYDROXY-M-TERPHENYLS HONSHU CHEMICAL IND (JP) 2017-03-29 EP disclosed
US-9102596-B2 Method of manufacturing 4,4″-dihydroxy-m-terphenyl HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2015-08-11 US disclosed
US-20150158800-A1 METHOD OF MANUFACTURING 4,4\"-DIHYDROXY-M-TERPHENYL HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2015-06-11 US disclosed
EP-2851359-A1 METHOD FOR PRODUCING 4,4''-DIHYDROXY-M-TERPHENYLS Honshu Chemical Industry Co., Ltd. (JP) 2015-03-25 EP disclosed
US-20130190529-A1 Fluorine Radiolabelling Process ISIS INNOVATION LIMITED (GB) 2013-07-25 US disclosed
US-8394995-B2 Process for preparation of carbonyl compound and pro-oxidant for preparation of carbonyl compound NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2013-03-12 US disclosed
US-20110009560-A1 ETHYLENICALLY UNSATURATED MONOMERS COMPRISING ALIPHATIC AND AROMATIC MOIETIES DOW GLOBAL TECHNOLOGIES INC. (US) 2011-01-13 US disclosed
EP-2265564-A1 ETHYLENICALLY UNSATURATED MONOMERS COMPRISING ALIPHATIC AND AROMATIC MOIETIES Dow Global Technologies Inc. (US) 2010-12-29 EP disclosed
WO-2009114466-A1 ETHYLENICALLY UNSATURATED MONOMERS COMPRISING ALIPHATIC AND AROMATIC MOIETIES DOW GLOBAL TECHNOLOGIES INC. (US) 2009-09-17 WO disclosed
US-7501535-B2 Chemical synthons and intermediates PURDUE RESEARCH FOUNDATION (US) 2009-03-10 US disclosed
EP-1871776-A2 FUSED THIENO[2,3-B]PYRIDINE AND THIAZOLO[5,4-B]PYRIDINE COMPOUNDS FOR INHIBITING KSP KINESIN ACTIVITY SCHERING CORPORATION (US) 2008-01-02 EP disclosed
US-20060247320-A1 Compounds for inhibiting KSP kinesin activity SCHERING CORPORATION 2006-11-02 US disclosed
WO-2006098961-A2 FUSED THIENO [2, 3-B] PYRIDINE AND THIAZOLO [5, 4-B] PYRIDINE COMPOUNDS FOR INHIBITING KSP KINESIN ACTIVITY SCHERING CORPORATION (US) 2006-09-21 WO disclosed
US-20040138485-A1 Chemical synthons and intermediates PURDUE RESEARCH FOUNDATION 2004-07-15 US disclosed
EP-0612783-B1 Cyanate resin composition and copper-clad laminate SUMITOMO CHEMICAL CO (JP) 1999-05-06 EP disclosed
US-5563237-A INCLUDES A BISMALEIMIDE HARDENER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1996-10-08 US disclosed
EP-0612783-A1 Cyanate resin composition and copper-clad laminate SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1994-08-31 EP disclosed
US-4882443-A Alkylene oxides production from C7 to C22 olefins using molten nitrate salt catalyst OLIN CORPORATION (US) 1989-11-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150158800-A1 METHOD OF MANUFACTURING 4,4\"-DIHYDROXY-M-TERPHENYL CYP1A1, CYP4B1, CYP1B1 NFKB1 2334/4885NFKB2 1640/4885RELA 1820/4885
US-20060247320-A1 Compounds for inhibiting KSP kinesin activity KIFC1, KIF5B, KIF2C NFKB1 2207/4885NFKB2 2546/4885RELA 2429/4885
US-20130190529-A1 Fluorine Radiolabelling Process ESRRG, NR5A2, RXFP4 NFKB1 1161/4885NFKB2 2712/4885RELA 3405/4885
US-20110009560-A1 ETHYLENICALLY UNSATURATED MONOMERS COMPRISING ALIPHATIC AND AROMATIC MOIETIES ELOB, ELOC, ELP1 NFKB1 1279/4885NFKB2 1000/4885RELA 2239/4885
US-20040138485-A1 Chemical synthons and intermediates STS, TST, CBS NFKB1 4695/4885NFKB2 4646/4885RELA 4162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.